Guntersleben, Germany

Udo Lorenz

This inventor holds 3 USPTO granted patents. Top assignees: Julius-Maximilians-Universitaet Wuerzburg, Julius-Maximilians-Universitat, Ludwig-Maximilians-Universitaet Muenchen. Active years: 2013-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Udo Lorenz. Retrieved from https://idiyas.com/inventor/udo-lorenz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 2.0

ph-index = 1


Location History:

  • Wurzburg, DE (2013)
  • Guntersleben, DE (2016 - 2017)

Company Filing History:


Years Active: 2013-2017

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Udo Lorenz: Innovator in Antibody Research

Introduction

Udo Lorenz is a notable inventor based in Guntersleben, Germany. He has made significant contributions to the field of antibody research, holding a total of 3 patents. His work focuses on the development of antibodies or fragments that target specific epitopes, showcasing his expertise in biochemistry and molecular biology.

Latest Patents

Udo Lorenz's latest patents include inventions that concern antibodies or fragments thereof that are directed against epitopes. These innovations are crucial for advancing therapeutic applications and enhancing our understanding of immune responses.

Career Highlights

Throughout his career, Udo Lorenz has worked with prestigious institutions, including Ludwig Maximilians University of Munich and Julius Maximilians University of Würzburg. His experience in these academic environments has allowed him to collaborate with leading researchers and contribute to groundbreaking studies in his field.

Collaborations

Udo Lorenz has collaborated with various professionals, including his coworker Knut Ohlsen. These partnerships have facilitated the exchange of ideas and fostered innovation in antibody research.

Conclusion

Udo Lorenz's contributions to the field of antibody research are noteworthy, and his patents reflect his commitment to advancing scientific knowledge. His work continues to influence the development of new therapeutic strategies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…